Blood tests could make kidney cancer drugs safer and more effective
NCT ID NCT04659343
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tracks drug levels in the blood of 200 people with advanced kidney cancer to see if monitoring can improve how well the drugs work and reduce side effects. Researchers will also look at how the body's immune system and genes affect treatment. The goal is to find better ways to personalize care for each patient.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG MECHANISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Oncology, Aarhus University Hospital
RECRUITINGAarhus, Danmark, 8200, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a One-Two punch of immune boosters revive cancer treatment?
- Can a pill that starves tumors of oxygen help fight advanced cancer?
- Could an ALS drug clear the fog of chemo brain?
- Ancient Mind-Body practice tested as fatigue fighter for men after cancer
- Can a website help cancer survivors live healthier? large study tests online lifestyle coaching
- Drug that starves tumors shows promise against advanced kidney cancer